Table 3.
Expected cost and QALY results
| Cost (95% CI) | QALY (95% CI) using McSad |
QALY (95% CI) using EQ-5D |
|
|---|---|---|---|
| ECT | €16 690 | 0.2137 | 0.4253 |
| rTMS | €16 858 | 0.1783 | 0.3988 |
| rTMS followed by ECT | €20 279 | 0.2631 | 0.4598 |
| Incremental | |||
| ECT v. rTMS | €−168 (€−4065 to 4294) | 0.0354 (−0.0319 to 0.0912) | 0.0265 (−0.0279 to 0.07423) |
| rTMS + ECT v. ECT | €3589 (€577 to 6664) | 0.0494 (0.0183 to 0.1148) | 0.0345 (−0.0094 to 0.1017) |
| ICER | |||
| ECT v. rTMS | ECT alone dominates | ECT alone dominates | |
| rTMS + ECT v. ECT | €72 668 | €103 953 | |
QALY, Quality adjusted life year; ECT, electroconvulsive therapy; rTMS, repetitive transcranial magnetic stimulation; ICER, incremental cost-effectiveness ratio; CI, confidence interval.